Biological Activities of Proteins and Marine-derived Peptides from Byproducts and Seaweeds

Marine Proteins and Peptides: Biological Activities and Applications

Volumn , Issue , 2013, Pages 139-165

  Hayes, Maria ^a  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

Bioactivity; Byproducts; Lectins; Marine derived peptides; Phycobiliproteins; Proteins; Seaweeds

Indexed keywords

EID: 84887232284     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118375082.ch7     Document Type: Chapter

References (147)

1. Adessi, C., Soto, C. (2002). Converting a Peptide into a Drug: Strategies to Improve Stability and Bioavailability, Current Medicinal Chemistry, 9, 963-978.
2. Ambrosio, A., L., Sanz, L., Sanchez, E. I., Wolfenstein-Todel, C., Calvete, J. J. (2003). Isolation of two novel mannan- and L-fucose binding lectins from the green alga Enteromorpha prolifera: biochemical characterization of EPL-2, Archives of Biochemistry and Biophysics, 415, 2, 245-250.
3. Amor, E. C., Vilasen, I., Yasirb, A., Choudhary, M., I. (2003). Prolyl Endopeptidase Inhibitors from Syzygium samarangense (Blume) Merr. and L. M. Perry, Z. Naturforsch., 59c, 86-92.
4. Andavan, G. S., Lemmens-Gruber, R. (2010). Cyclodepsipeptides from marine sponges: natural agents for drug research, Mar. Drugs. 8, 810-834.
5. Anderson, G. H., Luhovyy, B., Akhavan, T., Panahi, S. (2011). Milk proteins in the regulation of body weight, satiety, food intake and glycemia, milk and milk products in human nutrition. Nestĺe Nutr Inst Workshop Ser Pediatr Program, vol 67, pp. 147-159.
6. Arasoni, S., Karlsdottir, M., Valsdottir, T., Slizyte, R., Rustad, T., Falch, E., Eysturskard, J., Jakobsen, G. (2009). Maximum Resource Utilisation-Value Added Fish By-products, pp. 1-128.
7. Astawan, M., Wahyuni, M., Yasuhara, T., Tadokoro, T., Maekawa, A. (1995). Effects of angiotensin Iconverting enzyme inhibitory substances derived from Indonesian dried-salted fish on blood pressure of rats. Bioscience, Biotechnology, and Biochemistry, 59, 425-429.
8. Bazinet, L., Firdaous, L. (2009). Membrane processes and devices for separation of Bioactive Peptides, Recent Patents on Biotechnology, 3, 61-72.
9. Bittencourt, F. D. S., Figueiredo, J. G., Mota, M. R., Bezerra, C. C., Silvestre, P. P., Vale, M. R., Nascimento, K. S. (2008). Antinociceptive and anti-inflammatory effects of a mucin binding agglutinin isolated from the red marine alga Hypnea cervicornis, Naunyn-Schmiedeberg's Arch. Pharmacol., 377, 139-148.
10. Boyd, W. C. (1970). Lectins. Annals of the New York Academy of Sciences, 169, 168-190.
11. Brechtel, R., Watzig, H., Rudiger, H. (2001). The lectin from the mushroom Pleurotus ostreatus: a phosphatase-activating protein that is closely associated with an a-galactosidase activity. A part of this paper has been presented as a preliminary report at the 17th Interlec. Meeting 1997 in Ẅurzburg, Germany, 160, 5, 1025-1033.
12. Broggini, M., Marchini, S. V., Galliera, E., Borsotti, P., Taraboletti, G., Erba, E., Sironi, M., Jimeno, J., Faircloth, G.T, Giavazzi, R., D'Incalci, M. (2003). Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1). autocrine loop in human leukemia cells MOLT-4., Leukemia, 17, 1, 52-59.
13. B̈ussing, A., Suzart, K., Bergmann, J., Pfuller, U., Schietzel, M., Schweizer, K. (1996). Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Letters, 99, 1, 59-72.
14. Carluccio, M., Soccio, M., De Caterina, R. (2001). Aspects of gene polymorphism in cardiovascular disease: the renin angiotensin system. European Journal of Clinical Investigation, 31, 476-488.
15. Cha, S.-H., Lee, K.-W., Jeon, Y.-J. (2006). Screening of extracts from red algae in Jeju for potentials marine angiotensina-I-converting enzyme (ACE) inhibitory activity. Algae, 21, 343-348.
16. Chan, C.-X., Ho, C.-L., Phang, S.-M. (2006). Trends in seaweed research. Trends in Plant Science 11, 4, 165-166.
17. Coulombe, P. A., Omary, M. B. (2002). Hard and soft principles defining the structure, function and regulation of keratin intermediate filaments. Current Opinion in Cell Biology, 14, 110-122.
18. Cudennec, B., Ravallec-Ple, R., et al. (2008). Peptides from fish and crustacean by-products hydrolysates stimulate cholecystokinin release in STC-1 cells. Food Chemistry, 111, 4, 970-975.
19. Cushman, D. W., Cheung, H. S. (1971). Spectrophotometric assay and properties of the angiotensinconverting enzyme of rabbit lung. Biochem. Pharm., 26, 1637-1638.
20. Dauksas, E., Slizyte, R., Rustad, T., Storro, I. (2004). Bitterness in fish protein hydrolysates and methods for removal. Journal of Aquatic Food Product Technology, 13, 2, 101-104.
21. Dawczynski, C., Schubert, R., Jahreis, G. (2007). Amino acids, fatty acids and dietary fibre in edible seaweeds. Food Chemistry, 103, 3, 891-899.
22. Dayane, T. O., Lenize, C. R. M. C., Costa, C. A., Rocha, P. M., de Moura, R. S., Resende, A. C. (2012). Role of renin-angiotensin system and oxidative status on the maternal cardiovascular regulation in spontaneously hypertensive rats. American Journal of Hypertension 25, 498-504.
23. Deshmurkh, D. V., Puranik, P. R. (2012). Statistical evaluation of nutritional components impacting phycocyanin production in Synechocystis SP. Braz. J. Microbiol., 43, 1, 355.
24. Dong, S., Zeng, M., Wang, D., Liu, Z., Zhao, Y., Huicheng, Y. (2008). Antioxidant and biochemical properties of protein hydrolysates prepared from Silver carp. Food Chemistry, 107, 1483-1485.
25. Eisaf, M., Tselepis A. D. (2003). Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase: implications for atherosclerosis. Biochem. Pharmacol., 66, 11, 2069-2073.
26. Essuman, K. M. (1992). A study on processing, marketing and consumption of fermented fish in Africa. FAO: Rome.
27. Fitzgerald, C., Gallagher, E., Tasdemir, D., Hayes, M. (2011). Heart health peptides from macroalgae and their potential use in functional foods. J. Agric. Food Chem., 59 (13), 6829-6836.
28. Fleurence, J. (1999). Seaweed proteins: biochemical, nutritional aspects and potential uses. Trends in Food Science and Technology, 10, 1, 25-28.
29. Gimenez, B., Aleman, A., Montero, P., Gomez-Guillen, M. C. (2009). Antioxidant and functional properties of gelatin hydrolysates obtained from skin of sole and squid. Food Chemistry, 114, 976-983.
30. Glazer, A. N. (1994). Phycobiliproteins: a family of valuable, widely used fluorophores. Journal of Applied Phycology, 6, 2, 105-112.
31. Gross, P. L., Weitz, J. I. (2008). Venous thromboembolism: mechanisms, treatment and public awareness. New Anticoagulants for Treatment of Venous Thromboembolism, Artheriosclerosis, Thrombosis and Vascular Biology, 28, 380-386.
32. Gucute;on, T., Kristinsson, H. G. (2009). Bioactive peptides from marine sources: state of art. Report to the NORA fund, http://hdl.handle.net/10802/1453, last accessed 29 October 2012.
33. Harnedy, P. A., FitzGerald, R. J. (2011). Bioactive proteins, peptides, and amino acids from macroalgae. Journal of Phycology, 47, 218-232.
34. Hayes, M. (2011). Marine derived functional foods: claims and current legislation. In: Hayes, M., ed. Marine Bioactive Compounds: Sources, Characterisation and Applications. Springer: New York, pp. 207-225.
35. Hayes, M., Ross, R. P., FitzGerald, G. F., Hill, C., Stanton, C., Expand+Applied and Environmental Microbiologyaem.asm.org (2006a). Casein-derived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026. Appl. Environ. Microbiol., 72, 3, 2260-2264.
36. Hayes, M., Stanton, C., Slattery, H., O'Sullivan, O., Hill, C., FitzGerald, G. F., Ross, R. P. (2007). Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensinconverting enzyme inhibitors. Appl. Environ. Microbiol., 73, 14, 4658-4670.
37. Hayes, M., Ross, R. P., Fitzgerald, G. F., Hill, C., Stanton, C. (2006b). Casein-derived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026. Appl. Environ. Microbiol., 72, 2260-2264.
38. He, H.-L., Chen, X.-L., Wu, H., Sun, C.-Y., Zhang, Y.-Z., Zhou, B.-C. (2007). High throughput and rapid screening of marine protein hydrolysates enriched in peptides with angiotensin-I-converting enzyme inhibitory activity by capillary electrophoresis. Bioresource Technology, 98, 3499-3505.
39. Hiltunen, M., van Groen, T., Jolkkonen, J. (2009). Functional roles of amyloid-ß protein precursor and amyloid-ß peptides: evidence from experimental studies. Journal of Alzheimers Disease, 18, 2, 401-412.
40. Hori, K., Ikegami, S., Miyazawa, K., Ito, K. (1998). Mitogenic and antineoplastic isoagglutinins from the red alga Solieria robusta. Phytochemistry, 27, 2063-2067.
41. Howell, N. K., Kasase, C. (2010). Bioactive peptides and proteins from fish muscle and collagen. In: Mine, Y., Li-Chan, E., Jiang, B., eds. Bioactive Proteins and Peptides as Functional Foods and Nutraceuticals. Wiley-Blackwell: Iowa, pp. 203-225.
42. Huang, D., Ou, B., Prior, R. L. (2005). The chemistry behind antioxidant capacity assays. J. Agric. Food Chem., 53, 1841-1856.
43. Hurt-Camejo, E., Camejo, G., Peilot, H., Oomi, K., Kovanen, P. (2001). Phospholipase A2 in vascular disease. Circulation Research, 89, 298-304.
44. Hwang, E.-K., Amano, H., Park, C.-S. (2008). Assessment of the nutritional value of Capsosiphon fulvescens (Chlorophyta): developing a new species of marine macroalgae for cultivation in Korea. Journal of Applied Phycology, 20, 2, 147-151.
45. Imai, Y., Kuba, K., Penninger, J. M. (2008).The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp. Physiol., 93, 5, 548-554.
46. Ioannis, S. Arvanitoyannis, I. S., Palaiokostas, C., Panagiotaki, P. (2009). A comparative presentation of implementation of ISO 22000 versus HACCP and FMEA in a small size Greek factory producing smoked trout: a case study. Critical Reviews in Food Science and Nutrition, 49, 2, 176-201.
47. Je, J. Y., Park, P. J., Kim S. K. (2005). Antioxidant activity of a peptide isolated from Alaska pollack (Theragra chalcogramma) frame protein hydrolysate. Food Res Int., 38, 45-50.
48. Jeon, Y. J., Byun H. G., Kim S. K. (1999). Improvement of functional properties of cod frame protein hydrolysates using ultrafiltration membranes. Process Biochem., 35, 471-478.
49. Jimsheena, V. K., Gowda, L. R. (2010). Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure-activity relationship. Peptides, 31, 6, 1165-1176.
50. Jung, H. A., Hyun, S. K., Kim, H. R., Choi, J. S. (2006) Angiotensin-converting enzyme I inhibitory activity of phlorotannins from Ecklonia stolonifera. Fish. Sci., 72, 1292-1299.
51. Jung, W.-K., Rajapakse, N., Kim, S.-K. (2005). Antioxidant activity of a low molecular weight peptide derived from the sauce of fermented blue mussel, Mytilus edulis. European Food Research and Technology, 220, 5-6, 535-539.
52. Kang, K. H., Qian, Z. J., Ryu, B., Karadeniz, F., Kim, D., Kim, S. K. (2012). Antioxidant peptides from protein hydrolysate of microalgae Navicula incerta and their protective effects in Hepg2/CYP2E1 cells induced by ethanol. Phytotherapy Research, doi:10.1002/ptr.4603.
53. Kawakubo, A., Makino, H., Ohnishi, J., Hirohara, H., Hori, K. (1997). The marine red alga Eucheuma serra J. Agardh, a high yielding source of two isolectins. J. Applied Phycology, 9, 331-338.
54. Kawakubo, A., Makino, H., Ohnishi, J., Hirohara, H., Hori, K. (1999). Occurrence of highly yielded lectins homologous within the genus Eucheuma. J. Applied Phycology, 11, 149-156.
55. Kim, M. Y., Sohn, J. H., Ahn, J. S., Oh, H. (2009). Alternaramide, a cyclic depsipeptide from the marine-derived fungus Alternaria sp., SF-5016. J. Nat. Prod., 72, 2065-2068.
56. Kim, S. K., Ngo, D. H., Vo, T. S. (2012). Marine fish-derived bioactive peptides as potential antihypertensive agents. Adv Food Nutr Res., 65, 249-60.
57. Kim, S.-K., Wijesekara, I. (2010). Development and biological activities of marine-derived bioactive peptides: a review. Journal of Functional Foods, 2, 1, 1-9.
58. Kitts, D. D., Weiler, K. (2003). Bioactive proteins and peptides from food sources: applications of bioprocesses used in isolation and recovery. Current Pharmaceutical Design, 9, 16, 1309-1323.
59. Kohama, Y., Matsumoto, S., Oka, H., Teramoto, T., Okabe, M., Mimura, T. (1988). Isolation of angiotensin-converting enzyme inhibitor from tuna muscle. Biochemical and Biophysical Research Communications, 155, 332-337.
60. Kopec, A., Jamroz, D., Wiliczkiewicz, A., Biazik E. (2012). Antioxidation status and histidine dipeptides content in broiler blood and muscles depending on protein sources in feed. Journal of Animal Physiology and Animal Nutrition, doi:10.1111/j.1439-0396.2012.01303.x.
61. Kremp, A., Anderson, D. M. (2004). Lectin binding patterns of Scrippsiella lachrymosa (Dinophyceae) in relation to cyst formation and nutrient conditions. Journal of Experimental Marine Biology and Ecology, 307, 2, 165-181.
62. Kristinsson, H-G., Rasco, B. A. (2000). Fish protein hydrolysates: production, biochemical, and functional properties. Critical Reviews in Food Science and Nutrition, 40, 1, 43-81.
63. Kumar, R., Singh, V. P., Baker, K. M. (2009). The intraceulluar renin-angiotensin system in the heart. Current Hypertension Reports, 11, 2, 104-110.
64. Lahogue, V. K., Rehel, L., Taupin, D., Harras, P., Allaume, A. (2010). A HPLC-UV method for determination of angiotensin-I-convertign enzyme inhibitory activity. Food Chem., 118, 870-875.
65. Lahov, E., Regelson., W. (1996). Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides. Food Chem. Toxicol., 34, 131-145.
66. Lambeir, A.-M. (2011). Translational research on prolyl oligopeptidase inhibitors: the long road ahead. Expert Opinion on Therapeutic Patents, 21, 7, 977-981.
67. Lee, J.-H., Lee, S.-Y., Lee, K.-S., Jang, H.-J., Lee, K.-H., Hahn, T.-R., Paik, Y.-S. (2004). Prolyl endopeptidase inhibitors from the leaves of Ginkgo biloba. Planta Med., 70, 12, 1228-1230.
68. Li, G.-H., Le, G.-W., Shi, Y.-H., Shrestha, S. (2004). Angiotensin I-converting enzyme inhibitory peptides and their physiological and pharmacological effect. Nutrition Research, 24, 7, 469-486.
69. Liao, W. R., Lin, J. L., Shieh, W. Y., Jeng, W. L., Huang, R. (2003). Antibiotic activity of lectins from marine algae against marine vibrios. J. Ind. Microbiol. Biotechnol., 30, 433-439.
70. Lordan, S., Ross, R. P., Stanton, C. (2011). Marine bioactives as functional food ingredients: potential to reduce the incidence of chronic diseases. Marine Drugs, 9, 6, 1056-1100.
71. Lu, J., Sawano, Y., Miyakawa, T., Xue, Y.-L., Cai, N.-Y., Egashira, Y., Ren, D.-F. (2011). One-week antihypertensive effect of Ile-Gln-Pro in spontaneously hypertensive rats. J. Agric. Food Chem., 59, 2, 559-563.
72. Mabeau, S., Fleurence, J. (2003). Seaweed in food products: biochemical and nutritional aspects. Trends in Food Science & Technology, 4, 4, 103-107.
73. Madjid, M., Ali, M., Willerson, J. T. (2010). Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease. Tex. Heart Inst. J., 37, 1, 25-39.
74. Martinez, B., Rico, J. M. (2002). Seasonal variation of P content and major N content pools in Palmaria palmata (Rhodophyta). Journal of Phycology, 38, 1082-1089.
75. Matsubara, K., Sumi, H., Hori, K. (1996). Platelet aggregation is inhibited by phycolectins. Cell Mol. Life Sci, 52, 540-543.
76. Matsufuji, H., Matsui, T., Seki, E., Osajima, K., Nakashima, H., Osajima, K. (1994). Angiotensin Iconverting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle. Bioscience, Biotechnology, and Biochemistry, 58, 2244-2245.
77. Matsumura, N., Fujii, M., Takeda, Y., Sugita, K., Shimizu, T. (1993). Angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels autolysate. Bioscience, Biotechnology, and Biochemistry, 57, 695-697.
78. Meisel, H. (2004). Multifunctional peptides encrypted in milk proteins. BioFactors, 21, 55-61.
79. Mellander, O. (1950). The physiological importance of the casein phosphopeptide calcium salts. II. Peroral calcium dosage of infants. Acta Societatis Medicorum Uppsaliensis, 55, 247-255.
80. Mendis, E., Rajapakse, N., Byun, H. G., and Kim, S. K. (2005a). Investigation of jumbo squid (Dosidicus gigas) skin gelatin peptides for their in vitro antioxidant effects. Life Sciences, 77, 17, 2166-2178.
81. Mendis, E., Rajapakse, N., Kim, S. K. (2005b). Antioxidant properties of a radical-scavenging peptide purified from enzymatically prepared fish skin gelatin hydrolysate. J. Agric. Food Chem., 53, 581-587.
82. Miguel, M., Aleixandre, A. (2006). Antihypertensive peptides derived from egg proteins. J Nutr., 136, 6, 1457-1460.
83. Mills, S., Stanton, C., Hill, C., Ross, R. P. (2011). New developments and applications of bacteriocins and peptides in foods. Annual Review of Food Science and Technology, 2, 299-329.
84. Moraes, C. C., Sala, L., Cerveira, G. P., Kalil, S. J. (2011). C-phycocyanin extraction from Spirulina platensis wet biomass. Braz. J. Chem. Eng., 45-49.
85. Mori, T., O'Keefe, B. R., Sowder, R. C. II, Bringans, S., Gardella, R., Berg, S., Cochran, P. (2005). Isolation and characterization of griffithsin, a novel HIV inactivating protein, from the red alga Griffithsia sp. J. Biol. Chem., 280, 9345-9353.
86. Naeem, A., Saleemuddin, M., Khan, R. H. (2007). Glycoprotein targeting and other applications of lectins in biotechnology. Curr Protein Pept Sci., 2007, 8, 3, 261-271.
87. Nagano, C. S., Debray, H., Nascimento, K. S., Pinto, V. P. T., Cavada, B. S., Saker-Sampaio, S., Farias, W. R. L., Sampaio, A. H., Calvete, J. J. (2005). HCA and HML isolated from the red marine algae Hypnea cervicornis and Hypnea musciformis define a novel lectin family. Protein Science, 14, 2167-2176.
88. Nakamori, T. (2010). Soy peptides as functional food materials. In: Mine, Y., Li-Chan, E., Jiang, B., eds. Bioactive Proteins and Peptides as Functional Foods and Nutraceuticals. Wiley-Blackwell: Iowa, pp. 265-273.
89. Nasopoulou, C., Tsoupras, A. B., Karantonis, H. C., Demopoulos, C. A., Xabetakis, I. (2011). Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism. Lipids in Health and Disease, 10, 213.
90. Neves, S. A., Freitas, A. L. P., Souza, B. W. S., Rocha, M. L. A., Correia, M. V. O., Sampaio, D. A., Viana, G. S. B. (2007). Antinociceptive properties in mice of a lectin isolated from the marine alga Amansia multifida Lamouroux. Braz J. Med. Biol. Res., 40, 127-134.
91. Nomura, A., Noda, N., Muruyama, S. (2002). Purification of angiotensin I-converting enzyme inhibitors in pelagic thresher Alopias pelagicus muscle hydrolysate and viscera extracts. Fisheries Science, 68, 954-956.
92. Norris, R., Casey, F., FitzGerald, R. J., Shields, D., Mooney, C. (2012). Predictive modelling of Angiotensin converting enzyme inhibitory di-peptides. Food Chemistry, 133, 4, http://dx.doi.org/10.1016/j.foodchem.2012.02.023, last accessed 29 October 2012.
93. Ohba, R., Deguchi, T., Kishikawa, M., Morimura, S., Suzuki, I. (2003). Antioxidative effect of enzymatic hydrolysate of horn and hoof in rat. Food Sci. Technol. Res., 9 (2), 152-154.
94. Ohta, T., Iwashita, A., Sasaki, S., Hatano, M. (1997). Antihypertensive action of the orally administered protease hydrolysates of chum salmon head and their angiotensin I-converting enzyme inhibitory peptides. Food Science and Technology International, Tokyo, 3, 339.
95. Olson, A. M. and Lubchenco, J. (1990). Competition in seaweeds: linking plant traits to competitive outcomes. Journal of Phycology, 26, 1-6.
96. Ono, S., Hosokawa, M., Miyashita, K., Takahashi, K. (2003). Isolation of peptides with angiotensin I-converting enzyme inhibitory effect derived from hydrolysate of upstream chum salmon muscle. Journal of Food Science, 68, 1611-1614.
97. Ono, S., Hosokawa, M., Miyashita, K., Takahashi, K. (2006). Inhibition properties of dipeptides from salmon muscle hydrolysate on angiotensin I-converting enzyme. International Journal of Food Science & Technology, 41, 383-386.
98. Park, Y.-S., Jang, H.-J., Lee, H.-J., Lee, K.-H., Hahn, T.-R., Park, Y.-S. (2006). Prolyl endopeptidase inhibitory activity of unsaturated fatty acids. J. Agric. Food Chem., 54, 4, 1238-1242.
99. Picot, L., Ravallec, R., Fouchereau-Ṕeron, M., Vandanjon, L., Jaouen, P., Chaplain-Derouiniot, M., Gúerard, F., Chabeaud, A., LeGal, Y., Alvarez, O. M., Berǵe, J.-P., Piot, J.-M., Batista, I., Pires, C., Thorkelsson, G., Delannoy, C., Jakobsen, G., Johansson, I., Bourseau, P. (2010). Impact of ultrafiltration and nanofiltration of an industrial fish protein hydrolysate on its bioactive properties. J. Sci. Food Agric., 90, 1819-1826.
100. Pihlanto-Lepp̈al̈a, A. (2000). Bioactive peptides derived from bovine whey proteins: opioid and aceinhibitory peptides. Trends Food Sci Technol., 11, 347-356.
101. Plaza, A., Gustchina, E., Baker, H. L., Kelly, M., Bewley, C. A. (2007). Mirabamides A-D, depsipeptides from the sponge Siliquariaspongia mirabilis that inhibit HIV-1 fusion. J. Nat. Prod., 70:1753-1760.
102. Remuzzi, G., Perico, N., Macia, M., Ruggenenti, P. (2005). The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney International, 68, S57-S65.
103. Rho, S. J., Lee, J. S., Chung, Y. I., Kim, Y. W., Lee, H. G. (2009). Purification and identification of an angiotensin I-converting enzyme inhibitory peptide from fermented soybean extract. Process Biochem., 44, 490-493.
104. Ricci-Cabello, I., Olalla Herrera, M., Artacho, R. (2012). Possible role of milk-derived bioactive peptides in the treatment and prevention of metabolic syndrome. Nutrition Reviews, 70, 241-255.
105. Rival, S. G., Boerium, C. G., Wichers, H. J. (2001). Caseins and casein hydrolysates. 2. Antioxidative properties and relevance to lipoxygenase inhibition. J. Agric. Food Chem, 49, 295-300.
106. Rogers, D. J., Hori, K. (1993). Marine algal lectins: new developments. Hydrobiologia, 260-261, 1, 589-593.
107. Rustad, T. (2007). Physical and chemical properties of protein seafood by-products. In: Shahidi, F., ed. Maximising the Value of Marine By-products. Woodhead Publishing: Cambridge, UK, pp. 3-21.
108. Rustad, T., Storro, I., Slizyte, R. (2011). Possibilities for the utilisation of marine by-products. International Journal of Food Science and Technology, 46, 10, 2001-2014.
109. Rustad. T., Hayes, M. (2012). Marine bioactive peptides and protein hydrolysates: generation, isolation procedures and biological and chemical characterizations. In: Hayes, M., ed. Marine Bioactive Compounds: Sources, Characterization and Applications. Springer Science and Business Media: New York, pp. 99-115.
110. Saiga, A., Tanabe, S., Nishimura, T. (2003). Antioxidant activity of peptides obtained from porcine myofibrillar proteins by protease treatment. J. Agric. Food Chem., 2003, 51 (12), 3661-3667.
111. Samarakoon, K., Jeon, Y.-J. (2012). Bio-functionalities of proteins derived from marine algae: a review. Food Research International, http://dx.doi.org/10.1016/j.foodres.2012.03.013, last accessed 29 October 2012.
112. Sato, M., Hosokawa, T., Yamaguchi, T., Nakano, T., Muramoto, T., Kahara, K., Funayama, A. (2002). Angiotensin I-converting enzyme inhibitory peptides derived from wakame (Undaria pinnatifida) and their antihypertensive effect in spontaneously hypertensive rats. J. Agric. Food Chem., 50, 6245-6252.
113. Sekar, S., Chandramohan, M. (2008). Phycobiliproteins as a commodity: trends in applied research, patents and commercialization. Journal of Applied Phycology, 20, 113-136.
114. Sentandreu, M. A., Toldra, F. (2006). A fluorescence based protocol for quantifying angiotensin converting enzyme activity. Nature Protocols, 1, 5, 2423-2427.
115. Shahidi, F. (1994). Seafood processing by-products. In: Shahidi, F., Botta, J. R., eds. Seafoods Chemistry. Blackie Academic and Professional: London.
116. Smit, A. J. (2004). Medicinal and pharmaceutical uses of seaweed natural products: a review. Journal of Applied Psychology, 16, 245-262.
117. Sørensen, R., Kildal, E., Stepaniak, L., Pripp, A. H., Sørhaug, T. (2004). Screening for peptides from fish and cheese inhibitory to prolyl endopeptidase. Nahrung, 48, 53-56.
118. Stafforini, D. M. (2009). Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2). Cardiovascular Drugs and Therapy, 23, 1, 73-83.
119. Suarez-Jimenez, G.-M., Burgos-Hernandez, A., Ezquerra-Brauer, J.-M. (2012). Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals. Marine Drugs, 10, 963-986.
120. Suetsuna, K., Nakano, T. (2000). Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida). J. Nutr. Biochem., 11, 450-454.
121. Suetsuna, K., Saito, M. (2001). Enzyme-decomposed materials of laver and uses thereof. US Patent no. 621789B1.
122. Suetsuna, K., Maekawa, K., Chen, J.-R. (2004). Antihypertensive effects of Undaria pinnatifida (wakame) peptide on blood pressure in spontaneously hypertensive rats. Food Science and Technology International, 15, 5, 262-272.
123. Sugahara, T., Ohama, Y., Fukuda, A., Hayashi, M., Kawakubo, A., Kato, K. (2001). The cytotoxic effect of Eucheuma serra agglutinin (ESA) on cancer cells and its application to molecular probe for drug delivery system using lipid vesicles. Cytotechnology, 36, 93-99.
124. Teixeira, E. H., Napimoga, M. H., Carneiro, V. A., de Oliveira, T. M., Nascimento, K. S., Nagano, C. S., Souza, J. B. (2007). In vitro inhibition of oral streptococci binding to the acquired pellicle by algal lectins. J. Appl. Microbiol., 103, 1001-1006.
125. Thorkelsson, G., Kristinsson, H. H. (2009). Bioactive peptides from marine sources. State of Art Report to the NORA fund, Skyrsla Matis, 14-09, 19.
126. Thorkelsson, G., Slizyte, R. (2009). Fish proteins and peptide products: processing methods, quality and functional properties. In: Luten, J. B., ed. Marine Functional Food. Wageningen Academic Publishers: Wageningen, pp. 115-139.
127. Tierney, M. S., Croft, A. K., Hayes, M. (2010). A review of antihypertensive and antioxidant activities in macroalgae. Botanica Marina, 53, 387-408.
128. Townsend, R. R., McFadden, C. B., Ford, V., Cadée, J. A. (2004). A randomized, doubleblind, placebocontrolled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. Am J Hypertens., 17, 1056-1058.
129. Turk, B. (2006). Targeting proteases: successes, failures and future prospects. Nature Reviews Drug Discovery, 5, 785-799.
130. Turk, B., Stoka, V. (2007). Protease signalling in cell death: caspases versus cysteine cathepsins. FEBS Letters, 581, 15, 2761-2767.
131. Udenigwe, C. C., Aluko, R. E. (2012). Multifunctional cationic peptide fractions from flaxseed protein hydrolysates. Plant Foods Hum. Nutr., 67, 1-9.
132. Udenigwe, C. C, Li, H., Aluko, R. E. (2012). Quantitative structure-activity relationship modeling of renin-inhibiting dipeptides. Amino Acids, 42, 1379-1386.
133. Vasconcelos, I. M., Oliveira, J. T. A. (2004). Antinutritional properties of plant lectins. Toxicon, 44, 4, 385-403.
134. Vercruysse, L., Van Camp, J., Smagghie, G. (2005). ACE inhibitory peptides derived from enzymatic hydrolysates of animal muscle protein: a review. Journal of Agriculture and Food Chemistry, 53, 8106-8115.
135. Verdecchia, P., Angeli, F., Mazzotta, G., Gentile, G., Reboldi, G. (2008). The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction. Vasc. Health Risk Manag., 4, 5, 971-981.
136. Vermeirssen, V., Van Camp, J., Verstraete, W. (2004). Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br. J. Nutr., 92, 357-366.
137. Viana, G. S. B., Freitas, A. L. P., Lima, M. M. L., Vieira, L. A. P., Andrade, M. C. H., Benevides, N. M. B. (2002). Antiociceptive activity of sulphated carbohydrates from the red algae Bryothamnion seaforthii (Turner) Kutz. and B. triquetrum (S. G. Gmel.) M. Howe. Braz. J. Med. Biol. Res., 35, 713-722.
138. Weitz, J. I. (2011). Factor Xa and thrombin as targets for new oral anticoagulants. Thrombosis Research, 127, 2, S5-S12.
139. Wijesekara, I., Kim, S.-K. (2010). Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry. Marine Drugs, 8, 1080-1093.
140. Williams, R. B. (2004). Prolyl oligopeptidase and bipolar disorder. Clinical Neuroscience research, 4, 3-4, 233-242.
141. Wilson, J., Hayes, M., Carney, B. (2011). Angiotensin-I-converting enzyme and prolyl endopeptidase inhibitory peptides from natural sources with a focus on marine processing by-products. Food Chemistry, 129, 2, 235-244.
142. Wu, H.-C., Chen, H.-M., Shiau, C.-Y. (2003). Free amino acids and peptides as related to antioxidant properties in protein hydrolysates of mackerel (Scomber austriasicus). Food Research International, 36, 9-10, 949-957.
143. Yamamoto, N., Ejiri, M., Mizuno, S. (2003). Biogenic peptides and their potential use. Current Pharmaceutical Design, 9, 16, 1345-1355.
144. Yang, L. J. S., Zeller, C. B., Schnaar, R. L. (1996). Detection and isolation of lectin-transfected COS Cells based on cell adhesion to immobilized glycosphingolipids. Analytical Biochemistry, 5, 161-171.
145. Yang, R., Zhang, Z., Pei, X., et al. (2009). Immunomodulatory effects of marine oligopeptide preparation from Chum Salmon (Oncorhynchus keta) in mice. Food Chemistry, 113, 2, 464-470.
146. You, L. J., Zhao, M. M., Cui, C., Zhao, H. F., Yang, B. (2009). Effect of degree of hydrolysis on the antioxidant activity of loach (Misgurnus anguillicaudatus) protein hydrolysates. Inn. Food Sci. Emerg. Technol., 10, 235-240.
147. Zíolkowska, N. E., Wlodawer, A. (2006). Structural studies of algal lectins with anti-HIV activity. Acta Biochimica Polonica, 53, 4, 617-626.